Development of Magnetic Sensors for MRI Cancer Imaging

用于 MRI 癌症成像的磁传感器的开发

• 批准号: 6668909
• 负责人: J Manuel Perez
• 金额: $ 13.48万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-08-18 至 2008-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6668909
• 关键词: bioimaging /biomedical imaging; biomedical equipment development; enzyme activity; high throughput technology; magnetic resonance imaging; messenger RNA; molecular assembly /self assembly; molecular oncology; nanotechnology; oligonucleotides; protein protein interaction; technology /technique development; telomerase

DESCRIPTION (provided by applicant): The need to understand cancer biology at a cellular level requires a comprehensive interrogation of mRNA and proteins at high throughput and preferably simultaneously. The overall goal of the proposed research is to expand preliminary experiments by the applicant to further develop, validate and optimize magnetic nanosensors (magnetic relaxation switches, MRS) capable of sensing different types of molecular targets. In preliminary experiments we have shown that when monodisperse magnetic nanoparticles self-assemble into oligomeric nanoassemblies, there is a corresponding decrease in the spin-spin relaxation times (T2) of surrounding water detectable by NMR techniques. This fundamental observation has allowed us to measure DNA-DNA, protein-protein, small molecule protein interactions as well as enzyme activities (Nat Biotech 2002;20, 816-820). The magnetic relaxation switch (MRS) technique is exceedingly sensitive, allowing the detection of target molecules at femtomole levels with bench-top detectors and attomole levels by high-resolution MR imaging. The assay is performed in solution and does not require isolation or purification of the sample. In the proposed research the applicant will pursue three specific aims using telomerase as a cancer related target: (1) design and optimize MRS probes that independently recognize telomerase-mRNA, -protein and enzyme activity; (2) develop and optimize magnetic resonance techniques for simultaneous screening of telomerase-mRNA, -protein and -activity; and (3) develop and optimize internalization protocols for telomerase MRS probes that would allow detection of a target inside intact cells. It is hypothesized that telomerase mRNA, telomerase protein and telomerase activity can be detected in cell lysates and tissue extracts without prior purification or amplification using the developed MRS technique. Major biotechnical and medical applications of the developed technique lie in 1) the development of techniques to simultaneously interrogate RNA and proteins, 2) the development of high-throughput solution phase arrays, and 3) the ability to image molecular interactions by magnetic resonance imaging. The proposed research will be conducted in a multidisciplinary environment and the integrated training and research program will enable the candidate to establish himself as an independent cancer researcher.

描述（由申请人提供）：在细胞水平上了解癌症生物学的需要需要以高通量且优选同时地全面询问 mRNA 和蛋白质。 拟议研究的总体目标是扩大申请人的初步实验，以进一步开发、验证和优化能够感测不同类型分子目标的磁性纳米传感器（磁弛豫开关，MRS）。 在初步实验中，我们已经表明，当单分散磁性纳米颗粒自组装成低聚纳米组件时，可通过核磁共振技术检测到周围水的自旋-自旋弛豫时间（T2）相应减少。 这一基本观察使我们能够测量 DNA-DNA、蛋白质-蛋白质、小分子蛋白质相互作用以及酶活性 (Nat Biotech 2002;20, 816-820)。 磁弛豫开关 (MRS) 技术极其灵敏，可以通过台式探测器检测飞摩尔水平的目标分子，通过高分辨率 MR 成像检测阿托摩尔水平的目标分子。 该测定在溶液中进行，不需要分离或纯化样品。 在拟议的研究中，申请人将使用端粒酶作为癌症相关靶点来实现三个具体目标：（1）设计和优化独立识别端粒酶-mRNA、-蛋白质和酶活性的MRS探针； (2) 开发和优化磁共振技术，用于同时筛选端粒酶-mRNA、-蛋白和-活性； (3) 开发和优化端粒酶 MRS 探针的内化方案，以检测完整细胞内的靶标。 据推测，可以使用已开发的 MRS 技术检测细胞裂解物和组织提取物中的端粒酶 mRNA、端粒酶蛋白和端粒酶活性，而无需事先纯化或扩增。 所开发技术的主要生物技术和医学应用在于：1）同时询问RNA和蛋白质的技术的开发，2）高通量溶液相阵列的开发，以及3）通过磁共振成像对分子相互作用进行成像的能力。 拟议的研究将在多学科环境中进行，综合培训和研究计划将使候选人能够成为一名独立的癌症研究员。